Pivotal phase III trial of two dose levels of denileukin diftitox for the treatment of cutaneous T-cell lymphoma.
Overview of attention for article published in Journal of Clinical Oncology, January 2001
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (98th percentile)
-
High Attention Score compared to outputs of the same age and source (93rd percentile)
Mentioned by
- news
- 1 news outlet
- patent
- 15 patents
- wikipedia
- 2 Wikipedia pages
- guideline
- 4 clinical guideline sources
Readers on
- mendeley
- 128 Mendeley